Final 2025 Savings Ends in
- 00Days
- 00Hrs
- 00Mins
- 00Secs
17 - 19 March 2026
Austria CenterAustria Center, Vienna Manuel VegaCEO at AGS TherapeuticsSpeaker
Profile
Manuel is a biologist and serial entrepreneur with more than 30 years of experience in the biotech sector. Manuel was a postdoc and visiting researcher across leading institutes in Germany, France, and The Netherlands. He was the Founder and CEO of Nautilus Biotech (France and USA), a pioneering biotech company focused on directed evolution of proteins for long-lasting and oral variants (such as long-lasting interferon-alpha and oral human growth hormone). Nautilus Biotech filed INDs with FDA, and secured licensing deals with Aventis Pasteur, Serono, Wyeth Pharma and Hanall Pharmaceuticals. Since 2020, he’s co-founder and CEO of AGS Therapeutics.
Agenda Sessions
Workshop C: Targeted Delivery Approaches for ASOs, siRNA and next-gen mRNA Therapies
, 15:15View Session